RU2699791C1 - Method for production of bergenia dry extract nanocapsules - Google Patents

Abstract

FIELD: nanotechnologies; medicine; food industry.

SUBSTANCE: method for producing nanocapsules of dry extract of Bergenia is characterized by that dry extract of Bergenia is added to a suspension of kappa-carrageenan in petroleum ether in presence of 0.01 g of glycerol ester with one or two molecules of edible fatty acids and one or two molecules of citric acid as surface-active substance while stirring at 800 rpm, then 7 ml of fluorobenzene is poured, obtained suspension of nanocapsules is filtered and dried at room temperature, wherein mass ratio of core : shell is 1:1, 1:2 or 1:3.

EFFECT: disclosed is a method of producing nanocapsules of dry extract of Bergenia.

1 cl, 3 ex

Description

The invention relates to the field of nanotechnology, medicine, pharmacology and the food industry.

Previously known methods for producing microcapsules.

In US Pat. 2173140 IPC A61K 009/50, A61K 009/127 Russian Federation published September 10, 2001. A method for producing silicon-organolipid microcapsules using a rotary-cavitation unit with high shear forces and powerful sonar and ultrasonic sonar phenomena for dispersion is proposed.

The disadvantage of this method is the use of special equipment - a rotary cavitation unit, which has an ultrasonic effect, which affects the formation of microcapsules and can cause adverse reactions due to the fact that ultrasound destructively affects polymers of a protein nature, therefore, the proposed method is applicable when work with polymers of synthetic origin

In US Pat. 2359662 IPC A61K 009/56, A61J 003/07, B01J 013/02, A23L 001/00 published on 06/27/2009 The Russian Federation proposed a method for producing sodium chloride microcapsules using spray cooling in a Niro spray cooling tower under the following conditions: inlet air temperature 10 ° C, outlet air temperature 28 ° C, the rotation speed of the spray drum 10,000 rpm. The microcapsules of the invention have improved stability and provide controlled and / or prolonged release of the active ingredient.

The disadvantages of the proposed method are the duration of the process and the use of special equipment, a set of certain conditions (air temperature at the inlet 10 ° C, air temperature at the outlet 28 ° C, rotation speed of the spray drum 10,000 rpm).

The closest method is the method proposed in US Pat. 2134967 IPC A01N 53/00, A01N 25/28 published on 08.27.1999 Russian Federation (1999). A solution of a mixture of natural lipids and a pyrethroid insecticide in a weight ratio of 2-4: 1 in an organic solvent is dispersed in water, which simplifies the microencapsulation method.

The disadvantage of this method is dispersion in an aqueous medium, which makes the proposed method inapplicable for producing microcapsules of water-soluble preparations in water-soluble polymers.

The technical task is to simplify and accelerate the process of obtaining nanocapsules, reduce losses in obtaining nanocapsules (increase in yield by mass).

The solution to the technical problem is achieved by the method of producing nanocapsules, characterized in that kappa-carrageenan is used as the shell of the nanocapsules, and dry extract of badan is used as the core when nanocapsules are prepared by the non-solvent precipitation method using fluorobenzene as the precipitant.

A distinctive feature of the proposed method is the preparation of nanocapsules by non-solvent precipitation using fluorobenzene as a precipitant, as well as the use of kappa-carrageenan as a particle shell and dry frankincense extract as a core.

The result of the proposed method are obtaining nanocapsules of dry extract of frankincense.

EXAMPLE 1 Obtaining nanocapsules of dry extract of frankincense, the ratio of the core: shell 1: 3

1 g of dry extract of badan is added to a suspension of 3 g of kappa-carrageenan in petroleum ether in the presence of 0.01 g of the preparation E472c (glycerol ester with one or two molecules of food fatty acids and one or two molecules of citric acid, with citric acid as a tribasic , can be esterified with other glycerides and as an acid with other fatty acids. Free acid groups can be neutralized with sodium) as a surfactant with stirring at 800 rpm. Next, 7 ml of fluorobenzene is added. The resulting suspension is filtered and dried at room temperature.

Received 4 g of nanocapsule powder. The yield was 100%.

EXAMPLE 2 Obtaining nanocapsules of dry extract of frankincense, the ratio of the core: shell 1: 1

1 g of dry extract of badan is added to a suspension of 1 g of kappa-carrageenan in petroleum ether in the presence of 0.01 g of the preparation E472c as a surfactant with stirring at 800 rpm. Next, 7 ml of fluorobenzene is added. The resulting suspension is filtered and dried at room temperature.

Received 2 g of nanocapsule powder. The yield was 100%.

Example 3 Obtaining nanocapsules of dry extract of frankincense, the ratio of the core: shell 1: 2

1 g of dry extract of badan is added to a suspension of 2 g of kappa-carrageenan in petroleum ether in the presence of 0.01 g of the preparation E472c as a surfactant with stirring at 800 rpm. Next, 7 ml of fluorobenzene is added. The resulting suspension is filtered and dried at room temperature.

Received 3 g of nanocapsule powder. The yield was 100%.

Claims (1)

A method of producing nanocapsules of dry anabolic extract, characterized in that the dry anabolic extract is added to a suspension of kappa-carrageenan in petroleum ether in the presence of 0.01 g of glycerol ester with one or two molecules of edible fatty acids and one or two molecules of citric acid as a surface -active substance with stirring at 800 rpm, then 7 ml of fluorobenzene are poured, the resulting suspension of nanocapsules is filtered off and dried at room temperature, while the mass ratio of core: shell is 1: 1, 1: 2 or 1: 3.